Xeris Pharmaceuticals Inc (XERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XERS | ZTS | TAK | NBIX | UTHR |
| Company | Xeris Pharmaceuticals Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.7400 | 158.17 | 13.10 | 140.18 | 243.00 |
| High | 1.8300 | 160.78 | 13.28 | 145.22 | 258.48 |
| Low | 1.7300 | 158.04 | 13.08 | 136.01 | 236.65 |
| Last | 1.7500 | 158.50 | 13.19 | 143.03 | 255.14 |
| Change | unch | -0.74 | +0.11 | +5.49 | +20.81 |
| % Change | unch | -0.46% | +0.84% | +3.99% | +8.88% |
| Volume | 1,292,300 | 3,779,700 | 1,293,500 | 1,601,900 | 1,410,600 |
| 20-Day Average Volume | 1,301,630 | 4,556,170 | 1,687,160 | 802,105 | 531,355 |
| Previous Close | 1.7500 | 159.24 | 13.08 | 137.54 | 234.33 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.8500 | 156.48 | 13.32 | 136.60 | 236.46 |
| 20-Day Raw Stochastic | 14.29% | 55.71% | 24.03% | 85.49% | 88.39% |
| 20-Day Relative Strength | 34.28% | 44.00% | 39.12% | 58.55% | 64.44% |
| Weighted Alpha | -26.38 | -17.62 | -21.62 | +48.43 | +21.93 |
| Today's Opinion | 56% Sell | 72% Sell | 100% Sell | 88% Buy | 88% Buy |
| Previous Opinion | 56% Sell | 72% Sell | 100% Sell | 80% Buy | 64% Buy |
| Last Month's Opinion | 40% Sell | 56% Sell | 72% Sell | 88% Buy | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.57% since 04/24/24 | +5.05% since 04/24/24 | -0.30% since 04/24/24 | +2.92% since 04/24/24 | +7.65% since 04/24/24 |
| Low | 1.6900 on 04/26/24 | 150.04 on 04/25/24 | 13.01 on 04/26/24 | 135.17 on 04/26/24 | 233.31 on 04/30/24 |
| High | 1.8300 on 05/01/24 | 165.04 on 04/29/24 | 13.28 on 05/01/24 | 145.22 on 05/01/24 | 258.48 on 05/01/24 |
| 1-Month | |||||
| %Chg | -18.22% since 04/01/24 | -5.10% since 04/01/24 | -3.51% since 04/01/24 | +1.17% since 04/01/24 | +11.78% since 04/01/24 |
| Low | 1.6900 on 04/26/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 225.62 on 04/02/24 |
| High | 2.1250 on 04/02/24 | 169.39 on 04/05/24 | 13.77 on 04/08/24 | 145.22 on 05/01/24 | 258.48 on 05/01/24 |
| 3-Month | |||||
| %Chg | -30.28% since 02/01/24 | -16.20% since 02/01/24 | -8.28% since 02/01/24 | +0.41% since 02/01/24 | +18.14% since 02/01/24 |
| Low | 1.6900 on 04/26/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 3.2600 on 02/15/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 258.48 on 05/01/24 |
| 6-Month | |||||
| %Chg | -6.42% since 11/01/23 | +4.66% since 11/01/23 | -3.37% since 11/01/23 | +28.23% since 11/01/23 | +13.86% since 11/01/23 |
| Low | 1.4600 on 11/15/23 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 3.2600 on 02/15/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 258.48 on 05/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 259,444 | 72,829,848 | 41,396,068 | 13,686,192 | 11,027,334 |
| Shares Outstanding, K | 148,254 | 457,359 | 3,164,837 | 99,507 | 47,059 |
| Annual Sales | 163,910,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -62,260,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 44,390,000 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | -13,390,000 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | 2.33 | 0.85 | 0.53 | 0.25 | 0.52 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 03/06/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 1.44 on 02/07/24 | 4.36 on 02/21/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 30.02 | 6.75 | 57.39 | 12.01 |